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Background
microRNA (miRNA) is a class of non-coding RNAs, which
regulate gene expression at the post-transcriptional level.
Many miRNAs have been implicated in several human
cancers, as these regulatory molecules play important
roles in key cellular processes, including cell proliferation,
differentiation and response to DNA damage.
Methods
To gain insights into the mechanisms involved in breast
cancer initiation and progression we conducted a miRNA
global expression on 21T series. These cell lines repre-
sent an in vitro model of breast cancer progression com-
prising immortalized cell lines derived from the same
patient diagnosed with Her-2 overexpressing ductal car-
cinoma. The set include a normal epithelia (16N), pri-
mary in situ ductal carcinoma (21PT and 21NT) and
cells derived from pleural effusion of lung metastasis
(21MT-1 and 21MT-2). To confirm microarray results,
the expression of the most significantly altered miRNAs
were checked by qPCR. Matrigel invasion assay was done
to evaluate the migration capacity of 21Tcells and Her-2,
ZEB-1 and e-cadherin protein levels were achieved by
western blot.
Results
Analysis of 21T series revealed a significant downregula-
tion of miR-205 together with an enrichment of its pre-
dicted target, the pro-metastatic factor ZEB-1 and the
consequent reduction of e-cadherin levels in the invasive
21MT cells.
Conclusions
These molecular alterations, in special the downregulation
of miR-205 in cancer cells, can participate on modulation
of epithelial to mesenchymal transition and increase the
metastatic potential on breast cancer.
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